基于索赔数据与临床风险调整的退伍军人心力衰竭和肺炎住院患者死亡率趋势
这项观察性时间趋势研究分析了2009年1月至2015年9月期间VA医疗中心因心力衰竭、肺炎或脓毒症/呼吸衰竭伴肺炎次要诊断入院的患者,排除VA入组不足12个月、24小时内活着出院、违背医嘱离院和接受临终关怀者。主要终点为30天全因死亡率。索赔数据模型显示30天死亡率每季度下降:心衰0.051个百分点(95%CI -0.074至-0.027),肺炎0.084个百分点(95%CI -0.111至-0.056);而调整临床协变量后,这些变化减弱或消失:心衰-0.017个百分点/季度(95%CI -0.039至0.006),肺炎-0.026个百分点/季度(95%CI -0.052至0.001)。临床模型比索赔模型更准确区分30天后死亡与未死亡患者。作者结论认为,使用索赔数据风险调整评估30天死亡率时间趋势应谨慎解读。
要点
- 在146924例心衰入院和131325例肺炎入院中,未调整30天死亡率分别为6.45%和11.22%。
- 索赔数据模型显示预测30天死亡风险随时间增加:心衰每季度0.019个百分点(95%CI 0.015至0.023),肺炎每季度0.053个百分点(95%CI 0.043至0.063)。
- 临床模型显示预测风险下降或无变化:心衰每季度-0.014个百分点(95%CI -0.020至-0.008),肺炎每季度-0.004个百分点(95%CI -0.017至0.008)。
- 索赔数据风险调整显示30天死亡率下降:心衰每季度0.051个百分点(95%CI -0.074至-0.027),肺炎每季度0.084个百分点(95%CI -0.111至-0.056)。
- 调整临床协变量后变化减弱或消失:心衰每季度-0.017个百分点(95%CI -0.039至0.006),肺炎每季度-0.026个百分点(95%CI -0.052至0.001)。
适用人群与场景
- 纳入:2009年1月至2015年9月入住VA医疗中心、主要诊断为心力衰竭、肺炎或脓毒症/呼吸衰竭伴肺炎次要诊断的患者。
- 排除:VA入组不足12个月、24小时内活着出院、违背医嘱离院、接受临终关怀的患者。
研究设计与关键结果
- 研究类型:观察性时间趋势研究;样本量:146924例心衰入院(平均年龄71.6岁,98.4%男性)和131325例肺炎入院(平均年龄70.8岁,97.1%男性)。
- 未调整30天死亡率:心衰6.45%,肺炎11.22%。
- 索赔数据模型预测30天死亡风险随时间增加:心衰每季度0.019个百分点(95%CI 0.015至0.023),肺炎每季度0.053个百分点(95%CI 0.043至0.063)。
- 临床模型预测风险:心衰每季度-0.014个百分点(95%CI -0.020至-0.008),肺炎每季度-0.004个百分点(95%CI -0.017至0.008)。
- 索赔数据风险调整的30天死亡率变化:心衰每季度-0.051个百分点(95%CI -0.074至-0.027),肺炎每季度-0.084个百分点(95%CI -0.111至-0.056)。
- 调整临床协变量后的30天死亡率变化:心衰每季度-0.017个百分点(95%CI -0.039至0.006),肺炎每季度-0.026个百分点(95%CI -0.052至0.001)。
- 与索赔数据模型相比,心衰和肺炎的临床模型更准确区分30天后死亡与未死亡患者。
证据类型、等级与局限
- 证据类型:观察性时间趋势研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,使用索赔数据风险调整评估30天死亡率时间趋势应谨慎解读。
- 临床模型比索赔模型更准确区分30天后死亡与未死亡患者,提示在类似质量评估中可考虑纳入临床协变量。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Prior studies have reported declines in mortality for patients admitted to Veterans Health Administration (VA) and non-VA hospitals using claims-based risk adjustment. These apparent mortality reductions may be influenced by changes in coding practices.
OBJECTIVE: To compare trends in the VA for 30-day mortality following hospitalization for heart failure (HF) and pneumonia using claims-based and clinical risk-adjustment models.
DESIGN, SETTING, AND PARTICIPANTS: This observational time-trend study analyzed admissions to a VA Medical Center with a principal diagnosis of HF, pneumonia, or sepsis/respiratory failure (RF) with a secondary diagnosis of pneumonia. Exclusion criteria included having less than 12 months of VA enrollment, being discharged alive within 24 hours, leaving against medical advice, and hospice utilization.
EXPOSURES: Admission to a VA hospital from January 2009 through September 2015.
MAIN OUTCOMES AND MEASURES: The primary outcome was 30-day, all-cause mortality. All models included age and sex. Claims-based covariates included 22 (30) comorbidities for HF (pneumonia). Clinical covariates included vital signs, laboratory values, and ejection fraction.
RESULTS: Among the 146 924 HF admissions, the mean (SD) age was 71.6 (11.4) years and 144 502 (98.4%) were men; among the 131 325 admissions for pneumonia, the mean (SD) age was 70.8 (12.3) years and 127 491 (97.1%) were men. Unadjusted 30-day mortality rates were 6.45% (HF) and 11.22% (pneumonia). Claims-based models showed an increased predicted risk of 30-day mortality over time (0.019 percentage points per quarter for HF [95% CI, 0.015 to 0.023]; 0.053 percentage points per quarter for pneumonia [95% CI, 0.043 to 0.063]). Clinical models showed declines or no change in predicted risk (-0.014 percentage points per quarter for HF [95% CI, -0.020 to -0.008]; -0.004 percentage points per quarter for pneumonia [95% CI, -0.017 to 0.008]). Claims-based risk adjustment yielded declines in 30-day mortality of 0.051 percentage points per quarter for HF (95% CI, -0.074 to -0.027) and 0.084 percentage points per quarter for pneumonia (95% CI, -0.111 to -0.056). Models adjusting for clinical covariates attenuated or eliminated these changes for HF (-0.017 percentage points per quarter; 95% CI, -0.039 to 0.006) and for pneumonia (-0.026 percentage points per quarter; 95% CI, -0.052 to 0.001). Compared with the claims-based models, the clinical models for HF and pneumonia more accurately differentiated between patients who died after 30 days and those who did not.
CONCLUSIONS AND RELEVANCE: Among HF and pneumonia hospitalizations, adjusting for clinical covariates attenuated declines in mortality rates identified using claims-based models. Assessments of temporal trends in 30-day mortality using claims-based risk adjustment should be interpreted with caution.
参考来源
- Silva GC, Jiang L, Gutman R, et al. Mortality Trends for Veterans Hospitalized With Heart Failure and Pneumonia Using Claims-Based vs Clinical Risk-Adjustment Variables. JAMA Intern Med. 2020. PMID: 31860015. doi:10.1001/jamainternmed.2019.5970
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。